The development of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
serological tests is massive. The external validation of their performance is needed before …

Background The ongoing outbreak of the novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has posed a challenge for worldwide public health. A reliable …

The SARS-CoV-2 pandemic has challenged molecular microbiology laboratories to quickly
implement and validate diagnostic assays and to expand testing capacity in a short …

Rapid and accurate diagnosis is crucial for successful outbreak containment. During the
current coronavirus disease 2019 (COVID-19) public health emergency, the gold standard …

The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread
worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive …

The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is one of the most devastating outbreaks witnessed in the last 100 years. The outbreak …

At the time of this writing (late March 2020), the pandemic of novel coronavirus disease
(COVID-19) is rapidly expanding across much of the world, as it wanes in parts of Asia …

Following the first reports of coronavirus disease-19 (COVID-19) by China to the World
Health Organization (WHO) on 31st December 2019, more than 4,302,774 novel severe …

Objectives Serologic testing for severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has experienced a changing landscape of available assays coupled with uncertainty …

Although the most effective strategy for preventing or containing severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) outbreaks relies on early diagnosis, the paramount …